Managing type 2 diabetes in primary care: update on guidelines and best practice (Promotional content from Boehringer Ingelheim for healthcare professionals only) | GPnotebook TV

Managing type 2 diabetes in primary care: update on guidelines and best practice (Promotional content from Boehringer Ingelheim for healthcare professionals only) | GPnotebook TV

This promotional video has been developed, organised and funded by Boehringer Ingelheim. The content has been reviewed and approved by the sponsoring company prior to broadcast. The speakers have received an honorarium to take part in this promotional video. Editorial support for this video has been provided by OmniaMed Communications. GPnotebook TV has had no input into the content of the video.

Managing type 2 diabetes in primary care: update on guidelines and best practice (Promotional content from Boehringer Ingelheim for healthcare professionals only)

6 September 2022

Sponsored

Watch Dr Sarah Jarvis and Dr Amrit Lamba review the updated NICE NG28 type 2 diabetes guidance and discuss the implications of these changes for day-to-day clinical practice.

Prescribing information for Great Britain and Northern Ireland and the Republic of Ireland

Adverse events should be reported. Reporting forms and information can be found at https://www.mhra.gov.uk/yellowcard (UK) or https://www.hpra.ie/homepage/about-us/report-an-issue (IRE). Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone) (UK) or 01 2913960, Fax: +44 1344 742661, or by e-mail: [email protected] (IRE).

PC-GB-107166 | September 2022